Company Name
IGM Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US4495851085
CIK:
0001496323
CUSIP:
449585108
Currency:
USD
Full Time Employees:
16
Phone:
650 965 7873
Website:
https://igmbio.com
Fiscal Year End:
December
IPO Date:
Sep 18, 2019
Description:
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. As of August 14, 2025, IGM Biosciences, Inc. operates as a subsidiary of Concentra Biosciences, LLC.
Address:
325 East Middlefield Road, Mountain View, CA, United States, 94043